These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26410367)

  • 1. The role of inflammatory biomarkers in developing targeted cardiovascular therapies: lessons from the cardiovascular inflammation reduction trials.
    Passacquale G; Di Giosia P; Ferro A
    Cardiovasc Res; 2016 Jan; 109(1):9-23. PubMed ID: 26410367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
    Koenig W
    Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy.
    Thiele JR; Habersberger J; Braig D; Schmidt Y; Goerendt K; Maurer V; Bannasch H; Scheichl A; Woollard KJ; von Dobschütz E; Kolodgie F; Virmani R; Stark GB; Peter K; Eisenhardt SU
    Circulation; 2014 Jul; 130(1):35-50. PubMed ID: 24982116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of phospholipase A
    Kokotou MG; Limnios D; Nikolaou A; Psarra A; Kokotos G
    Expert Opin Ther Pat; 2017 Feb; 27(2):217-225. PubMed ID: 27718763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical appraisal of inflammatory markers in cardiovascular risk stratification.
    Krintus M; Kozinski M; Kubica J; Sypniewska G
    Crit Rev Clin Lab Sci; 2014 Oct; 51(5):263-79. PubMed ID: 24918900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins and other agents for vascular inflammation.
    Owens CD
    J Vasc Surg; 2012 Dec; 56(6):1799-806. PubMed ID: 23017371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atherosclerosis and arteriitis: implications for therapy of cardiovascular disease].
    Galle J
    Herz; 2004 Feb; 29(1):4-11. PubMed ID: 14968336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Inflammation to Reduce Residual Cardiovascular Risk.
    Ajala ON; Everett BM
    Curr Atheroscler Rep; 2020 Sep; 22(11):66. PubMed ID: 32880743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory effects of alpha-tocopherol.
    Singh U; Jialal I
    Ann N Y Acad Sci; 2004 Dec; 1031():195-203. PubMed ID: 15753145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory therapies for cardiovascular disease.
    Ridker PM; Lüscher TF
    Eur Heart J; 2014 Jul; 35(27):1782-91. PubMed ID: 24864079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory drugs and atherosclerosis.
    Moubayed SP; Heinonen TM; Tardif JC
    Curr Opin Lipidol; 2007 Dec; 18(6):638-44. PubMed ID: 17993809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inflammation, atherosclerosis and cardiovascular disease risk: PAPP-A, Lp-PLA2 and cystatin C. New insights or redundant information?].
    Piñón P; Kaski JC
    Rev Esp Cardiol; 2006 Mar; 59(3):247-58. PubMed ID: 16712749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging anti-inflammatory drugs for atherosclerosis.
    Berman JP; Farkouh ME; Rosenson RS
    Expert Opin Emerg Drugs; 2013 Jun; 18(2):193-205. PubMed ID: 23675745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combating Inflammation in Cardiovascular Disease.
    Sethwala AM; Goh I; Amerena JV
    Heart Lung Circ; 2021 Feb; 30(2):197-206. PubMed ID: 33039279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation, C-reactive protein, and atherothrombosis.
    Ridker PM; Silvertown JD
    J Periodontol; 2008 Aug; 79(8 Suppl):1544-51. PubMed ID: 18673009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pCRP-mCRP Dissociation Mechanisms as Potential Targets for the Development of Small-Molecule Anti-Inflammatory Chemotherapeutics.
    Caprio V; Badimon L; Di Napoli M; Fang WH; Ferris GR; Guo B; Iemma RS; Liu D; Zeinolabediny Y; Slevin M
    Front Immunol; 2018; 9():1089. PubMed ID: 29892284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation and cardiovascular disease: from pathogenesis to therapeutic target.
    Golia E; Limongelli G; Natale F; Fimiani F; Maddaloni V; Pariggiano I; Bianchi R; Crisci M; D'Acierno L; Giordano R; Di Palma G; Conte M; Golino P; Russo MG; Calabrò R; Calabrò P
    Curr Atheroscler Rep; 2014 Sep; 16(9):435. PubMed ID: 25037581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From Lipids to Inflammation: New Approaches to Reducing Atherosclerotic Risk.
    Shapiro MD; Fazio S
    Circ Res; 2016 Feb; 118(4):732-49. PubMed ID: 26892970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does low-density lipoprotein cholesterol induce inflammation? If so, does it matter? Current insights and future perspectives for novel therapies.
    Jukema RA; Ahmed TAN; Tardif JC
    BMC Med; 2019 Nov; 17(1):197. PubMed ID: 31672136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of anti-inflammatory agents for treatment of atherosclerosis.
    Chistiakov DA; Melnichenko AA; Grechko AV; Myasoedova VA; Orekhov AN
    Exp Mol Pathol; 2018 Apr; 104(2):114-124. PubMed ID: 29378168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.